39
ISSUE
Prostate News
September 2009
Better health at hand? Some interesting research projects explore how existing knowledge can translate into helpful new treatments for prostate cancer sufferers. PCFA supports more direct prostate cancer research than any other organisation in Australia. Last November we announced funding for more that $4 million worth of research projects into reducing the impact of prostate cancer on men and their families around the country. This support is only possible thanks to the extraordinary generosity of donors – especially everyone who has participated in Movember. Some of this research involves trailblazing work with gene therapy and immunotherapy or the development of new and potentially exciting drugs. Other research projects look at some tools we already have at hand to better our odds in the fight against prostate cancer and improve the quality of men’s health. Three of these projects are detailed here.
Can cholesterol drugs stop the spread of prostate cancer? Dr Michelle Hill
BSc/BA ’94, BSc Hons ’95, PhD ’00 Queensland
Even when prostate cancers have been removed, there is always a chance the cancer might come back. Recently, it’s been shown that a family of drugs called statins, originally used to reduce cholesterol, can also reduce the chance of prostate cancers returning. Scientists know that recurrent prostate cancers (cancers that come back) have high levels of a protein called Caveolin-1. Statins can switch this protein off, or alter what it does. This CONTINUED ON PAGE 3